Health Care; Pharmaceutical; Diagnostic; Biotech; Consumer Products; Medical Device; Manufacturing; Chemical; Media; Service; Technology
Abbott; Abbott Laboratories; Actelion; Alexion Pharmaceuticals; Allergan; Altus Biologics; Amgen; Amylin; ARIAD; Astellas; AstraZeneca; Bausch & Lomb; Baxter Healthcare; Baxter International; Bayer; Bayer Healthcare; Boehringer Ingelheim; Bristol-Myers Squibb; Cephalon; Dr Reddy's Laboratories; Eisai; Eli Lilly and Company; EMD Serono; Genentech; Genitope Corporation; Genzyme; GlaxoSmithKline; Human Genome Sciences; IDS Canada; Inc.; Inspire Pharmaceuticals; Integrated Communications Corp.; Intervet International (part of Schering-Plough); Janssen Cilag Pharmaceutical; Johnson & Johnson; Laboratorios Deramtologicos Darier; Lilly; Lundbeck; MedImmune; Merck; NeoVista; Neurocrine Biosciences; Nobel Biocare; Novartis; Noven Therapeuticals; Novo Nordisk; Onyx Pharmaceuticals; Pfizer; ProCaps Laboratories; ProStrakan; Quintiles; Regeneron; Roche; Sanofi-aventis; Shire; Smith & Nephew; Solvay Pharmaceuticals; Spectrum Pharmaceutical; Synapse biomedical; Takeda Pharmaceuticals; Talecris; Teva Neuroscience; Teva Pharmaceutical Industries Ltd; Ther-Rx; UCB Pharma; Vertex Pharmaceuticals; Xanodyne Pharmaceuticals
Who Can Benefit From These Services?
These services contain valuable material for each phase of the product launch cycle. Pharmaceutical executives and directors will find benchmarks useful for optimizing resources and staff, identifying trends and gaining a better understanding of the market, which will be beneficial in accomplishing their product launch objectives.